See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Liberation Day
Tariffs
Donald Trump
Trade War
Senate
Natural Disasters
Baseball
US Politics
Social Media
U.S.-Canada Relations
Republican Party
Trade
Published • loading... • Updated

Did Trump tank the FTC's insulin suit? Observers in Ohio, elsewhere want to know

Summary by Ohio Capital Journal
Billionaire Elon Musk, left accompanied by U.S. President Donald Trump, right, and Musk's son, X Musk, speaks during an executive order signing in the Oval Office at the White House on Feb. 11, 2025 in Washington, D.C. (Photo by Andrew Harnik/Getty Images)The Federal Trade Commission late Tuesday stayed a lawsuit accusing pharmacy middlemen of gaming the system to inflate the price of insulin — a drug millions of Americans need to survive. When …

3 Articles

All
Left
1
Center
Right
Ohio Capital JournalOhio Capital Journal
Left

Did Trump tank the FTC's insulin suit? Observers in Ohio, elsewhere want to know

Billionaire Elon Musk, left accompanied by U.S. President Donald Trump, right, and Musk's son, X Musk, speaks during an executive order signing in the Oval Office at the White House on Feb. 11, 2025 in Washington, D.C. (Photo by Andrew Harnik/Getty Images)The Federal Trade Commission late Tuesday stayed a lawsuit accusing pharmacy middlemen of gaming the system to inflate the price of insulin — a drug millions of Americans need to survive. When …

Read Full Article
globalcompetitionreview.comglobalcompetitionreview.com

FTC case against PBMs halted by firings

The Federal Trade Commission has been forced to pause its suit accusing OptumRX, CVS Caremark and Express Scripts of unfair pricing practices because President Donald Trump fired the commissioners overseeing the case. 

Read Full Article
CDR – Chain Drug ReviewCDR – Chain Drug Review

FTC pauses action against PBMs accused of scheme that raised insulin prices

WASHINGTON —The FTC has paused an enforcement action against pharmacy benefit managers alleging that they used an illicit rebate scheme that ended up raising insulin prices.The agency is suing PBMs including: Optum RX, part of UnitedHealth Group; CVS Caremark, owned by CVS Health and Express Scripts, a subsidiary of Cigna.FTC General Counsel Lucas Croslow, in an order, said the decision is due to not enough commissioners available to adjudicate …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CDR – Chain Drug Review broke the news in on Wednesday, April 2, 2025.
Sources are mostly out of (0)

Similar News Topics

Elon Musk

Elon Musk

UnitedHealth

UnitedHealth

FTC

FTC

United States

United States

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal